bluebird bio, Inc. (NASDAQ:BLUE) shares moved down -7.33% in last trading session and ended the day at $45.41. BLUE has a return on assets of -18.80%. bluebird bio, Inc. (NASDAQ:BLUE) quarterly performance is -13.09%.
bluebird bio, Inc. (NASDAQ: BLUE), announced that interim data from the ongoing Phase 2/3 Starbeam Study (ALD-102) for the treatment of cerebral adrenoleukodystrophy (CALD) will be presented in an oral presentation during the Clinical Trials plenary session on April 20, 2016 at the American Academy of Neurology (AAN) 2016 Annual Meeting. The meeting is being held April 15 – 21, 2016 in Vancouver, BC, Canada.
Perficient Inc. (NASDAQ:PRFT) ended the last trading day at $19.60. Company weekly volatility is calculated as 4.92% and price to cash ratio as 80.09. Perficient Inc. (NASDAQ:PRFT) showed a weekly performance of 6.00%.
On 3 March, Perficient Inc. (NASDAQ:PRFT) reported Revenue increased 4% to $473.6 million from $456.7 million for 2014; Services revenue increased 6% to $411.5 million from $386.7 million for 2014; Adjusted earnings per share results (a non-GAAP measure; see attached schedule, which reconciles to GAAP earnings per share) on a fully diluted basis decreased to $1.22 from $1.30 for 2014.
On 09 March, Intercontinental Hotels Group plc (NYSE:IHG) shares advanced 1.23% and was closed at $38.56. IHG EPS growth in last 5 year was 39.50%. Intercontinental Hotels Group plc (NYSE:IHG) year to date (YTD) performance is -0.46%.
InterContinental Hotels Group Plc, (NYSE:IHG) is seeking to add new luxury chains in that region, either by acquiring a competitor or by developing its own brand, according to Chief Executive Officer Richard Solomons.
Broadway Financial Corporation (NASDAQ:BYFC) shares advanced 10.39% in last trading session and ended the day at $1.70. BYFC has a return on assets of 2.50%. Broadway Financial Corporation (NASDAQ:BYFC) quarterly performance is 27.82%.
On 24 February, Broadway Financial Corporation (NASDAQ: BYFC), reported net income of $5.6 million, or $0.19 per diluted share, for the fourth quarter of 2015, compared to net income of $716 thousand, or $0.03 per diluted share for the fourth quarter of 2014.
NeuroDerm Ltd. (NASDAQ:NDRM) caters to the Healthcare space. Its weekly performance is -0.47%. On the last day of trading company shares ended up at $12.59.
NeuroDerm Ltd. (NASDAQ:NDRM), announced that CEO Oded S. Lieberman, PhD will present at the 28th Annual ROTH Conference taking place in Dana Point, California from March 13 – 16, 2016. Dr. Lieberman’s presentation will take place on Monday, March 14 at 9:30am PT, 12:30pm ET.
Leave a Reply